ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.898,80
1,23%
S&P 500
5.352,96
-0,02%
US Dollar vs BRL
5,2587
-0,81%
Bitcoin
70.806,80
-0,38%
Brent Oil
79,88
1,68%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Anadys Pharmaceuticals (MM) (ANDS)

  7. Anadys Pharmaceuticals (MM) (ANDS) Notícias

ANDS

Anadys (ANDS)

Anadys Pharmaceuticals (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANDS
DataHoraFonteTítuloCódigoCompanhia
23/11/201119:10Edgar (US Regulatory)(25-NSE)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
23/11/201117:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
23/11/201104:39Dow Jones NewsRoche Buys Shares In Tender Offer For Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
16/11/201109:02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
14/11/201119:55Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
08/11/201111:16MarketwiredAcquisition Spotlight Shines on Hepatitis C Drug DevelopersNASDAQ:ANDSAnadys Pharmaceuticals (MM)
07/11/201120:01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
07/11/201119:05PR Newswire (US)Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and HighlightsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
04/11/201118:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
26/10/201110:16MarketwiredPositive Test Results and Acquisitions Drive Shares of Exelixis and Anadys HigherNASDAQ:ANDSAnadys Pharmaceuticals (MM)
26/10/201108:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
25/10/201119:08Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
25/10/201118:25Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
24/10/201118:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
21/10/201112:53Business WireThe Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201117:39Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201108:08Dow Jones NewsRoche MS Drug's Good Test Results Boost Pipeline's ProspectsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201121:00Business WireFaruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201119:14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201115:12Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201101:30Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201111:00MarketwiredAnalyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LPNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201122:32Business WireRobbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201121:37Business WireRyan & Maniskas, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201116:42PR Newswire (US)The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys...NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201115:48Business WireTripp Levy PLLC Announces Investigation of Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201113:50ZacksRoche Targets Anadys Pharma - Analyst BlogNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201112:50Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201110:07PR Newswire (US)Anadys Announces Agreement To Be Acquired By RocheNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201103:49Dow Jones NewsRoche To Acquire Anadys Pharmaceuticals, Inc. For $230 MillionNASDAQ:ANDSAnadys Pharmaceuticals (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANDS

Seu Histórico Recente

BIT
P1W4N0
NLBNPIT1W4N0 20991231 27...
EU
IQEE
IndexIQ ETF
HITB
STEPNETH
GMT [STEPN]
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados